Women's health in emerging markets
Why can understanding and improving women’s health in emerging markets be challenging? What strategies can global pharma develop to support women and overcome these challenges? Associate Director Rachel Howard and Research Manager Helen Mace discuss why market research is useful for understanding behaviours and attitudes to different women’s health issues in emerging markets.
Why would a pharma company want to carry out a segmentation study? What are some of the challenges? Head of Business Analytics Tom Nolte and Associate Director Dr Marianne Jaeger discuss segmentation research.
Research Partnership mannequin challenge
Our UK executives took part in a Mannequin Challenge yesterday! They were keen to sample the culinary delights of the latest RP Bake-off, where staff bake and sell cakes to raise money for our chosen charity; Forever Angels baby home in Tanzania.
Self-pay and Emerging Markets
A key feature of emerging markets is that patients often have to pay for a high proportion of their healthcare costs themselves. For all but the most severe conditions, public reimbursement of medication is often partial to non-existent, particularly in the outpatient setting. In this video Emerging Markets Director Marc Yates discusses the opportunities and challenges for pharma in self-pay markets and outlines what these mean for healthcare market research.
Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high price tag and currently only a few of these drugs have actually reached the market including Opdivo, Keytruda and Yervoy. In this video Director Sue Marett discusses the opportunities and challenges for new immuno-oncology therapies and outlines what these mean for pharma market research.